The serum concentration of Atorvastatin can be increased when it is combined with Danazol. The risk or severity of adverse effects can be increased when Vinpocetine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Salbutamol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ergonovine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lapatinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sertaconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ribociclib. The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Valproic Acid is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The serum concentration of Atorvastatin can be decreased when it is combined with Deferasirox. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Brigatinib. The risk or severity of adverse effects can be increased when Lomitapide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Spirapril. The risk or severity of adverse effects can be increased when Regorafenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicotinamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Elbasvir is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isavuconazonium is combined with Atorvastatin. The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isoconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Saxagliptin. The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The risk or severity of adverse effects can be increased when Clomifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Paramethasone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Eperisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Omapatrilat. The risk or severity of adverse effects can be increased when Benidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Modafinil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cinnarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bicalutamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dimethyl sulfoxide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Posaconazole. The risk or severity of adverse effects can be increased when Progesterone is combined with Atorvastatin. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Capsaicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ergotamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 1,10-Phenanthroline. The risk or severity of adverse effects can be increased when Ambroxol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The serum concentration of Thioridazine can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Carboxyamidotriazole is combined with Atorvastatin. The serum concentration of Verapamil can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tramadol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Enasidenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lurasidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Antipyrine is combined with Atorvastatin. The serum concentration of Edoxaban can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The metabolism of Atorvastatin can be decreased when combined with Trimethoprim. The serum concentration of Lanthanum carbonate can be decreased when it is combined with Atorvastatin. The serum concentration of Aliskiren can be increased when it is combined with Atorvastatin. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Atorvastatin. The risk or severity of adverse effects can be increased when Miconazole is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Rifapentine. The serum concentration of Atorvastatin can be increased when it is combined with Telaprevir. The risk or severity of adverse effects can be increased when Lamotrigine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Repaglinide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Enalapril. Atorvastatin may increase the hypoglycemic activities of Glibornuride. The risk or severity of adverse effects can be increased when Desipramine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Argatroban. Gemfibrozil may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Bepridil is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with GM6001. The serum concentration of Naloxegol can be increased when it is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Insulin Human. The risk or severity of adverse effects can be increased when Nevirapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mefloquine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Lepirudin. The risk or severity of adverse effects can be increased when Sulfanilamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinorelbine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Phenobarbital. The serum concentration of Atorvastatin can be increased when it is combined with Rivaroxaban. The risk or severity of adverse effects can be increased when Irbesartan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tadalafil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Doxycycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ulinastatin. The serum concentration of Atorvastatin can be increased when it is combined with Vildagliptin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminium. The serum concentration of Atorvastatin can be decreased when it is combined with Sodium bicarbonate. The risk or severity of adverse effects can be increased when Cisapride is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliquidone. The risk or severity of adverse effects can be increased when Norfloxacin is combined with Atorvastatin. The serum concentration of Digoxin can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ticagrelor. The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Fosinopril. The serum concentration of Atorvastatin can be increased when it is combined with Aprotinin. The risk or severity of adverse effects can be increased when Lidocaine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziprasidone is combined with Atorvastatin. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vincristine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tesmilifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Risedronate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Dabrafenib. The risk or severity of adverse effects can be increased when Raloxifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metergoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Amlodipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Lopinavir. The risk or severity of adverse effects can be increased when Glycerol Phenylbutyrate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Delavirdine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Gabexate. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Atorvastatin. The serum concentration of Everolimus can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Bexarotene. The serum concentration of Atorvastatin can be increased when it is combined with Darexaban. The metabolism of Atorvastatin can be decreased when combined with Crisaborole. The serum concentration of Atorvastatin can be increased when it is combined with Apixaban. The serum concentration of Atorvastatin can be decreased when it is combined with Siltuximab. The risk or severity of adverse effects can be increased when Rucaparib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Sivelestat. The risk or severity of adverse effects can be increased when Econazole is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Fluindione. The serum concentration of Atorvastatin can be increased when it is combined with Ubenimex. The risk or severity of adverse effects can be increased when Temsirolimus is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lercanidipine is combined with Atorvastatin.